Try our beta test site
3 studies found for:    lymphoma [CONDITION] OR CLL [CONDITION] | Open Studies | Betalutin
Show Display Options
Rank Status Study
1 Not yet recruiting Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
Condition: Non-Hodgkin Lymphoma
Interventions: Drug: Betalutin with HH1 pre-dosing;   Drug: Betalutin with Rituximab pre-dosing
2 Recruiting Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-05)
Condition: Relapsed, Diffuse Large B-cell Lymphoma
Intervention: Drug: Betalutin
3 Recruiting A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
Condition: Non-Hodgkin Lymphoma
Intervention: Drug: Betalutin

Study has passed its completion date and status has not been verified in more than two years.